Zhengye Biotechnology Holding Limited Class A Ordinary Shares (ZYBT)
Stock · NASDAQ · Health Care
$1.4as of 10/16/2026
Price chart
Active signals
ZYBT Signal Track Record
How signals performed across all stocks →What ZYBT's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 10 | -13.7% | 20% | October 9, 2026 |
| Bollinger Band Breakdown | 3 | -33.3% | 0% | June 18, 2026 |
| Bollinger Band Breakout | 3 | -16.9% | 33% | October 9, 2026 |
| Any 20-session window (baseline) | -10.4% | 30% |
Computed by MarketWall from daily closing prices since October 23, 2025. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About ZYBT
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People's Republic of China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs, as well as monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. It also develops vaccines for household animals, including rabie…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 269
- Website
- ir.jlzybio.com/
Fundamentals
- 1-day range
- $1.38$1.85
- Market cap
- $99.05M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- $-1.93
- Dividend yield
- —
- Beta
- -0.64
- Avg. volume
- 5.61M
Zhengye Biotechnology Holding Limited Class A Ordinary Shares Competitors
Chosen by industry and closest market cap.
- ZYBTZhengye Biotechnology Holding Limited Class A Ordinary Shares$1.4▼ 6.67%Market cap $99.05MP/E —$0.6155$8.01
- RANIRani Therapeutics Holdings Inc. Class A Common Stock$0.641▼ 5.74%Market cap $96.76MP/E —$0.462$3.87
- ALDXAldeyra Therapeutics Inc. Common Stock$0.7▼ 5.02%Market cap $95.91MP/E —$0.8619$5.93
- ONCYOncolytics Biotech Inc. Common Stock$0.5▼ 9.09%Market cap $95.55MP/E —$1.48$4.49
- HRTXHeron Therapeutics Inc. Common Stock$0.36▼ 5.26%Market cap $94.45MP/E —$0.261$1.58
- RFLRafael Holdings Inc. Class B Common Stock$1.39▼ 5.44%Market cap $105.04MP/E —$1.12$3.96
- VRCAVerrica Pharmaceuticals Inc. Common Stock$3.6▼ 4.89%Market cap $92.08MP/E —$3.28$9.82
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ZYBT Zhengye Biotechnology Holding Limited Class A Ordinary Shares | $99.05M | — | $1.4 | ▼ 6.67% | $0.6155$8.01 |
| RANI Rani Therapeutics Holdings Inc. Class A Common Stock | $96.76M | — | $0.641 | ▼ 5.74% | $0.462$3.87 |
| ALDX Aldeyra Therapeutics Inc. Common Stock | $95.91M | — | $0.7 | ▼ 5.02% | $0.8619$5.93 |
| ONCY Oncolytics Biotech Inc. Common Stock | $95.55M | — | $0.5 | ▼ 9.09% | $1.48$4.49 |
| HRTX Heron Therapeutics Inc. Common Stock | $94.45M | — | $0.36 | ▼ 5.26% | $0.261$1.58 |
| RFL Rafael Holdings Inc. Class B Common Stock | $105.04M | — | $1.39 | ▼ 5.44% | $1.12$3.96 |
| VRCA Verrica Pharmaceuticals Inc. Common Stock | $92.08M | — | $3.6 | ▼ 4.89% | $3.28$9.82 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Friday's after hours session: top gainers and losersChartMill · 10/9/2026
- 12 Health Care Stocks Moving In Friday's After-Market SessionBenzinga · 10/9/2026
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
ZYBT listed among top after-hours movers
Zhengye Biotechnology was highlighted in recent market reports as one of the top gainers and losers in Friday's after-hours session. This movement places the stock in the broader group of health care names seeing activity outside regular trading hours. The share price has a wide 52-week range, reflecting the volatility typical for this issuer.
ZYBT listed among top after-hours movers. Zhengye Biotechnology was highlighted in recent market reports as one of the top gainers and losers in Friday's after-hours session. This movement places the stock in the broader group of health care names seeing activity outside regular trading hours. The share price has a wide 52-week range, reflecting the volatility typical for this issuer.